Related Experiment Video
Updated: Feb 8, 2026

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
High-Flow Nasal Cannula versus Conventional Oxygen Therapy in Children with Respiratory Distress
Punthila Sitthikarnkha1, Rujipat Samransamruajkit2, Nuanchan Prapphal1
1Department of Pediatrics, Division of Pulmonology, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Insights
High-flow nasal cannula (HFNC) therapy shows significant clinical benefits for pediatric respiratory distress, reducing treatment failure rates compared to conventional oxygen therapy. Early HFNC use may help avoid endotracheal intubation in children with moderate to severe distress.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Medicine
- Clinical Trials
Background:
- Respiratory distress is a common reason for hospitalization in infants and children.
- Conventional oxygen therapy is the standard treatment, but its efficacy can be limited in moderate to severe cases.
- High-flow nasal cannula (HFNC) therapy has emerged as a potential alternative.
Purpose of the Study:
- To compare the clinical efficacy of high-flow nasal cannula (HFNC) therapy versus conventional oxygen therapy in children with respiratory distress.
- To evaluate treatment failure rates and clinical improvements in pediatric patients receiving HFNC therapy.
Main Methods:
- A randomized controlled study was conducted involving 98 infants and children (1 month to 5 years) with respiratory distress.
- Participants were randomized into two groups: HFNC therapy and conventional oxygen therapy.
- Clinical data, including respiratory scores, pulse rate, and respiratory rate, were recorded and analyzed.
Main Results:
- Treatment failure occurred in 8.2% of the HFNC group versus 20.4% in the conventional oxygen group (P=0.09).
- After adjusting for covariates, HFNC therapy showed an 85% reduction in the odds of treatment failure (aOR 0.15, P=0.01).
- Significant improvements in respiratory scores and vital signs were observed in the HFNC group compared to the conventional oxygen group.
Conclusions:
- High-flow nasal cannula (HFNC) therapy demonstrates a potential clinical advantage in managing pediatric respiratory distress.
- Early implementation of HFNC therapy may help prevent the need for endotracheal intubation in children with moderate-to-severe respiratory distress.
Purpose:
The aim of this study is to determine the clinical efficacy of high-flow nasal cannula (HFNC) therapy compared with conventional oxygen therapy in children presented with respiratory distress.
Study Design:
This was a randomized controlled study.
Materials And Methods:
Infants and children aged between 1 month to 5 years who were admitted to our tertiary referral center for respiratory distress (July 1, 2014 to March 31, 2015) and met the inclusion criteria were recruited.
Interventions:
Infants and children hospitalized with respiratory distress were randomized into two groups of interventions. All clinical data, for example, respiratory score, pulse rate, and respiratory rate were recorded. The results were subsequently analyzed.
Results:
A total of 98 respiratory distress children were enrolled during the study period. Only 4 children (8.2%) failed in HFNC therapy, compared with 10 children (20.4%) in conventional oxygen therapy group (P = 0.09). After adjusted for body weight, underlying diseases, and respiratory distress score, there was an 85% reduction in the odds of treatment failure in HFNC therapy group (adjusted odds ratio 0.15, 95% confidence interval 0.03-0.66, P = 0.01). Most children in HFNC therapy group had significant improvement in clinical respiratory score, heart rate, and respiratory rate at 240, 360, and 120 min compared with conventional oxygen therapy (P = 0.03, 0.04, and 0.03).
Conclusion:
HFNC therapy revealed a potential clinical advantage in management children hospitalized with respiratory distress compared with conventional respiratory therapy. The early use of HFNC in children with moderate-to-severe respiratory distress may prevent endotracheal tube intubation.
Trial Register:
TCTR 20170222007.
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Sign Convention
The normal force acts perpendicular to the beam's cross-section and can...
Enolate Mechanism Conventions
Nose and Nasal Cavity

